When h3ACs were treated with camostat mesylate, a serine protease inhibitor active against TMPRSS2, SARS-CoV-2 entry and progression were partially blocked, corroborating that the activity of TMPRSS2 is required for viral infection of hAT2 cells (Figure S3D). Here, TMPRSS2 is linked to viral infectious disease.